| __timestamp | ACADIA Pharmaceuticals Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 26684000 |
| Thursday, January 1, 2015 | 90804000 | 29829000 |
| Friday, January 1, 2016 | 186456000 | 39578000 |
| Sunday, January 1, 2017 | 255062000 | 43277000 |
| Monday, January 1, 2018 | 265758000 | 48645000 |
| Tuesday, January 1, 2019 | 325638000 | 52934000 |
| Wednesday, January 1, 2020 | 388661000 | 61349000 |
| Friday, January 1, 2021 | 396028000 | 127125000 |
| Saturday, January 1, 2022 | 369090000 | 136106000 |
| Sunday, January 1, 2023 | 402466000 | 133175999 |
Unleashing insights
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, ACADIA Pharmaceuticals Inc. and HUTCHMED (China) Limited have shown contrasting trends in their SG&A efficiency.
From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking in 2023. This growth reflects their aggressive expansion and investment in administrative capabilities. However, such a rise also poses questions about cost management and profitability.
Conversely, HUTCHMED's SG&A expenses grew by approximately 400% during the same period. While their growth is significant, it remains more controlled compared to ACADIA, suggesting a more conservative approach to administrative spending.
These trends highlight the strategic differences between the two companies, offering insights into their operational priorities and financial strategies.
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
CRISPR Therapeutics AG or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Catalyst Pharmaceuticals, Inc. and HUTCHMED (China) Limited
HUTCHMED (China) Limited vs ImmunityBio, Inc.: SG&A Expense Trends
HUTCHMED (China) Limited or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Viridian Therapeutics, Inc.